| human | Q5 |
| P496 | ORCID iD | 0000-0002-1082-3321 |
| P1153 | Scopus author ID | 10642141900 |
| P69 | educated at | Seoul National University | Q39913 |
| P108 | employer | Samsung Medical Center | Q624119 |
| Mayo Clinic Hospital — Rochester | Q2212928 | ||
| Cleveland Clinic | Q4117596 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q80481047 | 15-deoxyspergualin prevents mucosal injury by inhibiting production of TNF-alpha and down-regulating expression of MD-1 in a murine model of TNBS-induced colitis |
| Q37718547 | A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients |
| Q38448135 | A new technique for complete portal vein and superior mesenteric vein thrombosis in a liver transplant recipient. |
| Q47825124 | ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor. |
| Q39618430 | AFT024 cell line in co-culture system using high pore density insert (HPDI) maintains hematopoietic stem/progenitor cells (HSCs/HPCs) as more primitive state through histone modification |
| Q37084152 | Adeno-Associated Virus 2-Mediated Hepatocellular Carcinoma is Very Rare in Korean Patients |
| Q43970258 | Alemtuzumab induction in deceased donor kidney transplantation |
| Q53171579 | Anatomic similarity of the hepatic artery and portal vein according to the donor-recipient relationship. |
| Q38446412 | Antiviral treatment for hepatitis B virus recurrence following liver transplantation. |
| Q41886697 | Application of temporary inflow control of the Glissonean pedicle method provides a safe and easy technique for totally laparoscopic hemihepatectomy by Glissonean approach |
| Q83175431 | Auxiliary partial orthotopic living donor liver transplantation in a patient with alcoholic liver cirrhosis to overcome donor steatosis |
| Q36193413 | Bile duct reconstruction by a young surgeon in living donor liver transplantation using right liver graft |
| Q80799589 | Biliary reconstruction using the cystic duct in right lobe living donor liver transplantation |
| Q36816063 | C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion |
| Q34046640 | CDK4 amplification predicts recurrence of well-differentiated liposarcoma of the abdomen |
| Q38486040 | Can preemptive kidney transplantation guarantee longer graft survival in living-donor kidney transplantation? Single-center study. |
| Q38445768 | Can the kidney weight and recipient body weight ratio predict long-term graft outcome in living donor kidney transplantation? |
| Q37715059 | Can the model for end-stage liver disease score replace the indocyanine green clearance test in the selection of right hemihepatectomy in Child-Pugh class A? |
| Q38481794 | Cartilage oligomeric matrix protein-angiopoientin-1 enhances angiogenesis of isolated islet and maintains normoglycemia following transplantation. |
| Q40860739 | Case-matched comparison of ABO-incompatible and ABO-compatible living donor liver transplantation. |
| Q42222236 | Change of hepatitis B virus DNA and covalently closed circular DNA status in liver graft after liver transplantation |
| Q51773154 | Changes in T Cells After ABO-Incompatible Liver Transplantation. |
| Q38445682 | Characteristics of recipients who achieved spontaneous operational tolerance in adult liver transplantation |
| Q54498863 | Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - a prospective study. |
| Q33636181 | Clinical outcomes of laparoscopic radiofrequency ablation of single primary or recurrent hepatocellular carcinoma (≤3 cm). |
| Q46369091 | Clinical significance of posttransplantation vesicoureteral reflux during short-term period after kidney transplantation |
| Q51348024 | Clinical significance of proteinuria at posttransplant year 1 in kidney transplantation. |
| Q41187045 | Clinicopathological factors and long-term outcome comparing between lung and peritoneal metastasectomy after hepatectomy for hepatocellular carcinoma in a tertiary institution |
| Q82690387 | Coagulation abnormalities in deceased donors are associated with unsuccessful human islet cell isolation |
| Q53554342 | Combined use of myeloid-related protein 8/14 and procalcitonin as diagnostic markers for acute allograft rejection in kidney transplantation recipients. |
| Q38445643 | Comparison between resection and transplantation in combined hepatocellular and cholangiocarcinoma. |
| Q83396325 | Comparison between thymoglobulin and ATGAM as an induction agent in adult kidney transplantation: a single-center experience |
| Q38445692 | Comparison of the incidence of de novo malignancy in liver or kidney transplant recipients: analysis of 2673 consecutive cases in a single center. |
| Q87574629 | Comparison of the tolerance of hepatic ischemia/reperfusion injury in living donors: macrosteatosis versus microsteatosis |
| Q47967721 | Conversion of once-daily extended-release tacrolimus is safe in stable liver transplant recipients: A randomized prospective study |
| Q41101796 | De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers |
| Q53504782 | Development of functional human immune system with the transplantations of human fetal liver/thymus tissues and expanded hematopoietic stem cells in RAG2-/-gamma(c)-/- MICE. |
| Q42261925 | Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis |
| Q42756205 | Differences in Peripheral Blood Lymphocytes between Brand-Name and Generic Tacrolimus Used in Stable Liver Transplant Recipients |
| Q53377515 | Differentiation and major histocompatibility complex antigen expression in human liver-derived stem cells. |
| Q83149988 | Differentiation of liver transplantation complications by quantitative analysis of dynamic hepatobiliary scintigraphy |
| Q58078415 | Does meeting the Milan criteria at the time of recurrence of hepatocellular carcinoma after curative resection have an impact on prognosis? |
| Q38486023 | Donor characteristics associated with reduced survival of transplanted kidney grafts in Korea. |
| Q83491797 | Donor morbidity including biliary complications in living-donor liver transplantation: single-center analysis of 827 cases |
| Q37026107 | Early Enteral Feeding After Living Donor Liver Transplantation Prevents Infectious Complications: A Prospective Pilot Study |
| Q38485952 | Early and delayed onset cytomegalovirus infection of liver transplant recipients in endemic areas. |
| Q55054561 | Early disseminated recurrence after liver resection in solitary hepatocellular carcinoma. |
| Q50690956 | Early postoperative renal dysfunction in the adult living donor liver transplantation. |
| Q99347916 | Effect of CYP3A5 on the Once-Daily Tacrolimus Conversion in Stable Liver Transplant Patients |
| Q40519922 | Effect of early enteral nutrition after hepatectomy in hepatocellular carcinoma patients |
| Q53377532 | Effect of fulminant hepatic failure porcine plasma supplemented with essential components on encapsulated rat hepatocyte spheroids. |
| Q48029952 | Effectiveness of intraportal prostaglandin E1 administration after liver transplantation |
| Q57225691 | Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria |
| Q41855731 | Encapsulating peritoneal sclerosis in liver transplant recipients: a report of 2 cases |
| Q53334219 | Enhanced significance of donor-recipient age gradient as a prognostic factor of graft outcome in living donor kidney transplantation. |
| Q43594551 | Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression |
| Q53284674 | Expanded criteria for liver transplantation in patients with hepatocellular carcinoma. |
| Q38499933 | Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma |
| Q37226397 | Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study. |
| Q46843919 | Feasibility of C2 monitoring in Korean renal transplantation |
| Q35820962 | Feasibility of laparoscopic liver resection for giant hemangioma of greater than 6 cm in diameter. |
| Q95839246 | Feasibility of laparoscopic liver resection for liver cavernous hemangioma: A single-institutional comparative study |
| Q33812778 | Functional Evaluation of a Bioartificial Liver Support System Using Immobilized Hepatocyte Spheroids in a Porcine Model of Acute Liver Failure |
| Q42232195 | HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma |
| Q53559120 | HCC in living donor liver transplantation: can we expand the Milan criteria? |
| Q41435877 | Hepatectomy is a reasonable option for older patients with hepatocellular carcinoma |
| Q45397669 | Hepatitis B virus vaccine switch program for prevention of de novo hepatitis B virus infection in pediatric patients. |
| Q35033798 | Hepatobiliary scintigraphy for detecting biliary strictures after living donor liver transplantation. |
| Q53380643 | Hepatocellular carcinoma in an infant with biliary atresia younger than 1 year. |
| Q33627472 | High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients |
| Q51347994 | Hormonal differences between female kidney transplant recipients and healthy women with the same gynecologic conditions. |
| Q60932912 | Impact of technical innovation on surgical outcome of laparoscopic major liver resection: 10 years' experience at a large-volume center |
| Q53377509 | In vitro evaluation of migratory capacity of human liver stem cells influenced by soluble factors. |
| Q36152454 | Incidental microscopic bile duct tumor thrombi in hepatocellular carcinoma after curative hepatectomy: a matched study |
| Q42182001 | Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load |
| Q43241169 | Influence of human allogenic bone marrow and cord blood-derived mesenchymal stem cell secreting trophic factors on ATP (adenosine-5'-triphosphate)/ADP (adenosine-5'-diphosphate) ratio and insulin secretory function of isolated human islets from cada |
| Q33285443 | Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model. |
| Q38475761 | Is cytomegalovirus infection dangerous in cytomegalovirus-seropositive recipients after liver transplantation? |
| Q84757363 | Is it safe to use a kidney from an expanded criteria donor? |
| Q79635182 | Isolation and characterization of mouse mesenchymal stem cells |
| Q38402222 | Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area. |
| Q38445581 | Jejunal artery can be a useful option for arterial reconstruction in living donor liver transplantation when the suitable arterial inflow is absent. |
| Q39204964 | Kidney donation after cardiac death in Korea |
| Q84757359 | Kidneys from deceased donors with oliguria are feasible for kidney transplantation |
| Q90941521 | Learning curve of laparoscopic living donor right hepatectomy |
| Q53377512 | Live cell-imaging perfusion culture system of liver sinusoidal endothelial cells to mimic stem cell engraftment in liver. |
| Q43541048 | Liver transplantation for hepatocellular carcinoma with bile duct thrombi |
| Q42260052 | Liver transplantation in lymphoma patients with hepatitis B virus reactivation |
| Q38485980 | Living donor liver transplantation in Budd-Chiari syndrome: a single-center experience. |
| Q53351763 | Living donor liver transplantation using a graft from a donor with situs inversus totalis. |
| Q45175992 | Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation. |
| Q93004386 | Long-term Outcome of Endoscopic Retrograde Biliary Drainage of Biliary Stricture Following Living Donor Liver Transplantation |
| Q83377114 | Long-term protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation |
| Q50499648 | Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. |
| Q83180561 | Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired |
| Q38445734 | Monitoring and treatment for BK virus after kidney transplantation. |
| Q50992882 | Monitoring of cytomegalovirus-specific CD8+ T-cell response with major histocompatibility complex pentamers in kidney transplant recipients. |
| Q46454872 | Mycophenolate mofetil promotes down-regulation of expanded B cells and production of TNF-alpha in an experimental murine model of colitis |
| Q38486015 | Mycophenolic acid trough level measurements and clinical outcomes in kidney transplantation recipients on a fixed dose (1.5 g/d) of mycophenolate mofetil in Korea. |
| Q37530522 | Nonanatomical resection is comparable with anatomical resection in solitary hepatocellular carcinoma <5 cm in the right posterior section |
| Q91607635 | One-Year Recipient Morbidity of Liver Transplantation Using Pure Laparoscopic Versus Open Living Donor Right Hepatectomy: Propensity Score Analysis |
| Q34429511 | Optimal tailored screening protocol after living donor liver transplantation for hepatocellular carcinoma |
| Q35571656 | Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients. |
| Q43497954 | Outcome of donors with a remnant liver volume of less than 35% after right hepatectomy |
| Q38832283 | Outcome of living donor liver transplantation using right liver allografts with multiple arterial supply. |
| Q40782819 | Outcome of partial reconstruction of multiple hepatic arteries in pediatric living donor liver transplantation using left liver grafts |
| Q44705200 | Outcome of patients with recurrent hepatocellular carcinoma in liver transplantation |
| Q42196212 | Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver |
| Q36476188 | Outcomes for patients with HCV after liver transplantation in Korea: a multicenter study |
| Q45412090 | Outcomes of hepatitis B virus recurrence after liver transplantation |
| Q87362045 | Outcomes of simultaneous laparoscopic colorectal and hepatic resection for patients with colorectal cancers: a comparative study |
| Q51252229 | PIVKA-II is a useful marker in patients with modified UICC T3 stage hepatocellular carcinoma. |
| Q47289243 | Peroneal neuropathy after liver transplantation |
| Q38485971 | Pharmacokinetics of mycophenolic acid in living donor liver transplantation. |
| Q38890186 | Pneumatosis intestinalis after adult liver transplantation |
| Q38478033 | Posteromedial diaphragmatic hernia following pediatric liver transplantation. |
| Q53377528 | Potentiality of immobilized pig hepatocyte spheroids in bioartificial liver system. |
| Q37206110 | Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods. |
| Q53284663 | Prediction of biliary complications after living-donor liver transplantation based on serum cytokine profile. |
| Q84905569 | Predictors of the feasibility of primary endoscopic management of biliary strictures after adult living donor liver transplantation |
| Q38445726 | Presence of vesicoureteral reflux in the graft kidney does not adversely affect long-term graft outcome in kidney transplant recipients. |
| Q35006131 | Primary hepatic neuroendocrine carcinoma. |
| Q53588698 | Prognosis after liver transplantation predicted by preoperative MELD score. |
| Q53521749 | Prolonged cold ischemic time is a risk factor for biliary strictures in duct-to-duct biliary reconstruction in living donor liver transplantation. |
| Q39399043 | Prospective, randomized study of ropivacaine wound infusion versus intrathecal morphine with intravenous fentanyl for analgesia in living donors for liver transplantation |
| Q53339547 | Protein induced by vitamin K antagonist-II (PIVKA-II) is a reliable prognostic factor in small hepatocellular carcinoma. |
| Q42105387 | Protrusion of hepatocellular carcinoma is a predictor of early recurrence in hepatectomy patients after spontaneous rupture |
| Q43591874 | Rabbit antithymocyte globulin compared with basiliximab in kidney transplantation: a single-center study |
| Q38367959 | Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. |
| Q38498361 | Reconstitution of human lymphocytes following ex vivo expansion of human umbilical cord blood CD34+ cells and transplantation in Rag2-/- gamma c-/- mice model. |
| Q57212430 | Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation |
| Q46369097 | Renal transplantation in patients with a small bladder |
| Q38307483 | Repeated Hepatic Resection versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Hepatic Resection: A Propensity Score Matching Study. |
| Q38485934 | Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia. |
| Q36052307 | Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution. |
| Q39671926 | Role of Human Leukocyte Antigen Compatibility in Graft Outcomes After Living Donor Liver Transplantation |
| Q42199455 | SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma |
| Q51786066 | Safety of donors with fatty liver in liver transplantation. |
| Q38484028 | Safety of small-for-size grafts in adult-to-adult living donor liver transplantation using the right lobe. |
| Q102381778 | Serial Observations of Muscle and Fat Mass as Prognostic Factors for Deceased Donor Liver Transplantation |
| Q38451853 | Significance of true-positive and false-positive pretransplantation lymphocytotoxic crossmatch in primary liver allograft outcomes. |
| Q37697585 | Single hepatocellular carcinoma ≤ 3 cm in left lateral segment: liver resection or radiofrequency ablation? |
| Q38423200 | Single-Center Experience of Consecutive 522 Cases of Hepatic Artery Anastomosis in Living-Donor Liver Transplantation. |
| Q53062573 | Single-center experience of living donor liver transplantation in patients with portal vein thrombosis. |
| Q38358321 | Small Hepatocellular Carcinoma: Radiofrequency Ablation versus Nonanatomic Resection--Propensity Score Analyses of Long-term Outcomes |
| Q46457444 | Steatosis among living liver donors without evidence of fatty liver on ultrasonography: potential implications for preoperative liver biopsy. |
| Q82944402 | Steroid withdrawal in adult liver transplantation: occurrence at a single center |
| Q53595236 | Steroid withdrawal in living donor renal transplant recipients using tacrolimus and cyclosporine: a randomized prospective study. |
| Q38799152 | Streamline flow of the portal vein affects the lobar distribution of colorectal liver metastases and has a clinical impact on survival |
| Q51822027 | Surgical Techniques for Totally Laparoscopic Caudate Lobectomy. |
| Q57221007 | Sustained linear growth and preserved renal function in 10-year survivors of pediatric liver transplantation |
| Q42776181 | The comparison of the perioperative changes in lactate and prothrombin time between deceased versus living donor liver transplantation |
| Q38454619 | The different etiology of fulminant hepatic failure (FHF) in Korea and prognostic factors in patients undergoing liver transplantation for FHF. |
| Q36686983 | The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma. |
| Q84409981 | The effect of human fetal liver-derived mesenchymal stem cells on CD34+ hematopoietic stem cell repopulation in NOD/Shi-scid/IL-2Rã(null) mice |
| Q48179540 | The effects of desflurane and isoflurane on hepatic and renal functions after right hepatectomy in living donors |
| Q43183850 | The effects of desflurane and sevoflurane on hepatic and renal functions after right hepatectomy in living donors*. |
| Q83627744 | The effects of intermittent inflow occlusion and hepatic steatosis on postoperative liver functions in living liver donors undergoing right hepatectomy |
| Q81309492 | The hepatic regeneration power of mild steatotic grafts is not impaired in living-donor liver transplantation |
| Q50580620 | The phenotypic characteristic of liver-derived stem cells from adult human deceased donor liver. |
| Q36383864 | The prognosis in cases of hepatocellular carcinoma after hepatectomy: young patients versus older patients. |
| Q38485943 | The risk factors for cytomegalovirus syndrome and tissue-invasive cytomegalovirus disease in liver transplant recipients who have cytomegalovirus antigenemia. |
| Q38486049 | The risk factors of delayed graft function and comparison of clinical outcomes after deceased donor kidney transplantation: single-center study. |
| Q51010143 | Tips for pure laparoscopic right hepatectomy in the live donor. |
| Q37175958 | Tissue expander placement and adjuvant radiotherapy after surgical resection of retroperitoneal liposarcoma offers improved local control. |
| Q81259040 | Tolerance induction through megadose bone marrow transplantation with two-signal blockade |
| Q46783532 | Tolerance induction through simultaneous double bone marrow transplantation with two-signal blockade |
| Q34451876 | Trend and outcome of Korean patients receiving overseas solid organ transplantation between 1999 and 2005. |
| Q47418249 | Use of Dexmedetomidine in Liver Transplant Recipients With Postoperative Agitated Delirium |
| Q37485617 | Withdrawal of immunosuppression in pediatric liver transplant recipients in Korea. |
Search more.